Darko Bosnakovski

7PUBLICATIONS
36CO-AUTHORS
Molecular targetsMedical virologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 17, 2025
Development of p300-targeting degraders with enhanced selectivity and onset of degradation.

Graham P Marsh, Mark S Cooper, Sean Goggins

|Mar 21, 2024
The homeobox transcription factor DUXBL controls exit from totipotency.

Maria Vega-Sendino, Felipe F Lüttmann, Teresa Olbrich

|Feb 06, 2024
Skin muscle is the initial site of viral replication for arboviral bunyavirus infection.

Christine A Schneider, Jacqueline M Leung, Paola Carolina Valenzuela-Leon

|Jan 30, 2023
Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein.

Darko Bosnakovski, Erik A Toso, Elizabeth T Ener

|Oct 13, 2021
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.

Darko Bosnakovski, Elizabeth T Ener, Mark S Cooper

Pageof 2